tradingkey.logo

Danaher Corp

DHR
View Detailed Chart

188.540USD

-1.510-0.79%
Close 09/15, 16:00ETQuotes delayed by 15 min
134.98BMarket Cap
39.55P/E TTM

Danaher Corp

188.540

-1.510-0.79%
Intraday
1m
30m
1h
D
W
M
D

Today

-0.79%

5 Days

-5.08%

1 Month

-10.61%

6 Months

-10.53%

Year to Date

-17.87%

1 Year

-31.25%

View Detailed Chart

TradingKey Stock Score

Currency: USD Updated2025-09-15

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
38 / 207
Overall Ranking
142 / 4724
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 26 analysts
Buy
Current Rating
242.621
Target Price
+27.66%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three business segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a range of instruments, consumables, services and software that are primarily used by customers to study genomics and the basic building blocks of life, including deoxyribonucleic acid (DNA)and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 20.13%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 20.13%.
Fairly Valued
The company’s latest PE is 39.77, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 670.76M shares, increasing 0.05% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 60.48M shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.06.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three business segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a range of instruments, consumables, services and software that are primarily used by customers to study genomics and the basic building blocks of life, including deoxyribonucleic acid (DNA)and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
Ticker SymbolDHR
CompanyDanaher Corp
CEOMr. Rainer M. Blair
Websitehttps://www.danaher.com/
KeyAI